Integer (ITGR) Competitors

$120.92
+1.92 (+1.61%)
(As of 05/17/2024 ET)

ITGR vs. MASI, LIVN, TMDX, CNMD, SLNO, INMD, CRNX, PACS, SMMT, and INSM

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Masimo (MASI), LivaNova (LIVN), TransMedics Group (TMDX), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), Crinetics Pharmaceuticals (CRNX), PACS Group (PACS), Summit Therapeutics (SMMT), and Insmed (INSM). These companies are all part of the "medical" sector.

Integer vs.

Integer (NYSE:ITGR) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Integer presently has a consensus target price of $128.67, indicating a potential upside of 6.41%. Masimo has a consensus target price of $138.71, indicating a potential upside of 11.78%. Given Masimo's higher probable upside, analysts clearly believe Masimo is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Masimo
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Integer had 4 more articles in the media than Masimo. MarketBeat recorded 20 mentions for Integer and 16 mentions for Masimo. Integer's average media sentiment score of 0.65 beat Masimo's score of 0.48 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
8 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Masimo
3 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Integer has higher earnings, but lower revenue than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.60B2.54$90.65M$2.8941.84
Masimo$2.05B3.22$81.50M$1.4784.42

Integer has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Integer has a net margin of 6.01% compared to Masimo's net margin of 4.01%. Masimo's return on equity of 13.26% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.01% 11.25% 5.69%
Masimo 4.01%13.26%5.87%

99.3% of Integer shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 2.0% of Integer shares are owned by insiders. Comparatively, 9.7% of Masimo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Masimo received 76 more outperform votes than Integer when rated by MarketBeat users. Likewise, 63.84% of users gave Masimo an outperform vote while only 63.51% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
376
63.51%
Underperform Votes
216
36.49%
MasimoOutperform Votes
452
63.84%
Underperform Votes
256
36.16%

Summary

Integer and Masimo tied by winning 9 of the 18 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$4.05B$3.40B$5.17B$18.10B
Dividend YieldN/A1.65%43.85%3.44%
P/E Ratio41.846.81114.2522.02
Price / Sales2.5466.592,365.0111.39
Price / Cash14.9868.6336.3719.45
Price / Book2.664.415.746.01
Net Income$90.65M$87.99M$105.63M$965.99M
7 Day Performance6.10%1.47%1.83%1.87%
1 Month Performance2.66%0.95%4.72%7.16%
1 Year Performance50.01%6.68%7.83%21.68%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MASI
Masimo
4.637 of 5 stars
$136.00
-1.4%
$137.43
+1.1%
-26.1%$7.20B$2.05B90.075,200High Trading Volume
LIVN
LivaNova
1.3673 of 5 stars
$63.12
+0.8%
$66.20
+4.9%
+34.5%$3.42B$1.15B-105.202,900Short Interest ↓
TMDX
TransMedics Group
2.7035 of 5 stars
$127.28
-4.0%
$119.00
-6.5%
+83.1%$4.19B$241.62M-374.35584Insider Selling
CNMD
CONMED
4.9927 of 5 stars
$71.65
+1.3%
$107.86
+50.5%
-37.1%$2.21B$1.24B27.454,000Short Interest ↓
SLNO
Soleno Therapeutics
3.8375 of 5 stars
$46.80
+1.9%
$55.60
+18.8%
+973.5%$1.56BN/A-15.7633
INMD
InMode
2.8439 of 5 stars
$18.50
-0.8%
$32.80
+77.3%
-44.0%$1.55B$492.05M8.77581Short Interest ↑
CRNX
Crinetics Pharmaceuticals
3.8181 of 5 stars
$47.66
+2.5%
$54.00
+13.3%
+129.5%$3.75B$4.01M-12.88290Analyst Forecast
Insider Selling
Short Interest ↓
PACS
PACS Group
1.6694 of 5 stars
$24.99
+0.2%
$30.50
+22.0%
N/A$3.75BN/A0.0032,433Analyst Forecast
Quiet Period Expiration
SMMT
Summit Therapeutics
1.3731 of 5 stars
$5.31
+18.8%
$8.00
+50.7%
+162.7%$3.73B$700,000.00-33.19105Gap Up
High Trading Volume
INSM
Insmed
4.5171 of 5 stars
$26.08
+0.5%
$44.92
+72.2%
+33.5%$3.87B$305.21M-4.88373Analyst Forecast
Insider Selling
Short Interest ↓
Analyst Revision
News Coverage

Related Companies and Tools

This page (NYSE:ITGR) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners